Drug intelligence / Profile preview

Ankun Tablets

Development stage: Unknown
Lead developer: Buchang Pharmaceutical Group
Administration: Oral

Overview

Ankun Tablets is a Traditional Chinese Medicine (TCM) product developed and manufactured by Shanxi Buchang Pharmaceutical. It is approved in China for the treatment of various gynecological diseases, particularly those involving menstrual irregularities, dysmenorrhea, and blood deficiency. The formulation is designed to nourish blood, regulate menstruation, and soothe the liver, following traditional Chinese medical principles for female reproductive health. As a TCM tablet, it consists of multiple botanical extracts that work synergistically to balance hormonal activity and improve pelvic blood circulation.

Brand names: AnkunAnkun Tablets
Other names: Ankun PianAnkun Granules

Beyond the preview

Go deeper on Ankun Tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankun Tablets.

Explore the full profile